Volume 12, Number 3—March 2006
Dispatch
Molecular Analysis of Fluoroquinolone-resistant Salmonella Paratyphi A Isolate, India
Table 2
Country | Year | MIC (μg/mL) |
|||||
---|---|---|---|---|---|---|---|
Cp | Nal | qnr | gyrA | parC | Reference | ||
India | 1999 | 0.38 | >256 | ND | Ser83→Phe | ND | (8) |
Bangladesh | 1999 | 0.5 | >256 | ND | Asp87→Gly | ND | (8) |
India | 1999 | 0.5 | >256 | ND | Ser83→Phe | ND | (8) |
Hong Kong | 2000 | 0.5 | >256 | ND | Ser83→Tyr | NM | (9) |
Japan | 2002 | >128 | >256 | ND | Ser83→Phe, Asp87→Asn | Glu84→Lys | (7) |
India | 2002 | 8 | >256 | NP | Ser83→Phe, Asp87→Gly | Ser80→Arg† | This study |
*No mutations were detected in gyrB and parE. Cp, ciprofloxacin; Nal, nalidixic acid; ND, not determined; NP, not present; NM, no mutation within the quinolone resistance–determining region.
†European Molecular Biology Laboratory accession no. AM050347.
References
- Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82:346–53.PubMedGoogle Scholar
- Sood S, Kapil A, Dash N, Das BK, Goel V, Seth P. Paratyphoid fever in India: an emerging problem. Emerg Infect Dis. 1999;5:483–4. DOIPubMedGoogle Scholar
- Yang J, Dong B, Wang M, Tang Z, Gong J, Li C, An analysis of S. Paratyphi A and S. Typhi prevalence in Guangxi autonomous region between 1994–2002 [article in Chinese]. China Trop Med. 2004;a:177–18.
- Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis. 2000;6:420–1. DOIPubMedGoogle Scholar
- Wain J, Hoa NT, Chinh NT, Vinh H, Everett MJ, Diep TS, Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis. 1997;25:1404–10. DOIPubMedGoogle Scholar
- Harish BN, Madhulika U, Parija SC. Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp. enterica serotype Paratyphi A. J Med Microbiol. 2004;53:819. DOIPubMedGoogle Scholar
- Adachi T, Sagara H, Hirose K, Watanabe H. Fluoroquinolone-resistant Salmonella Paratyphi A. Emerg Infect Dis. 2005;11:172–4.PubMedGoogle Scholar
- Walker RA, Skinner JA, Ward LR, Threlfall EJ. LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in gyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin. Int J Antimicrob Agents. 2003;22:622–5. DOIPubMedGoogle Scholar
- Ling JM, Chan EW, Lam AW, Cheng AF. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother. 2003;47:3567–73. DOIPubMedGoogle Scholar
- Piddock LJ. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev. 2002;26:3–16.PubMedGoogle Scholar
- Eaves DJ, Randall L, Gray DT, Buckley A, Woodward MJ, White AP, Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother. 2004;48:4012–5. DOIPubMedGoogle Scholar
- Piddock LJ, Ricci V, McLaren I, Griggs DJ. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom. J Antimicrob Chemother. 1998;41:635–41. DOIPubMedGoogle Scholar
- Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother. 2004;48:1295–9. DOIPubMedGoogle Scholar
- Selander RK, Beltran P, Smith NH, Helmuth R, Rubin FA, Kopecko DJ, Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect Immun. 1990;58:2262–75.PubMedGoogle Scholar
- Chandel DS, Nisar N, Thong KL, Pang T, Chaudhry R. Role of molecular typing in an outbreak of Salmonella paratyphi A. Trop Gastroenterol. 2000;21:121–3.PubMedGoogle Scholar
Page created: January 27, 2012
Page updated: January 27, 2012
Page reviewed: January 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.